June 13, 2017 6:16pm
It ain’t over as the cell therapy sector jumped … the short-term oversold has their acquittal
Even as the sector rises, there were few easy or juicy trades …
As I had stated, “Downside trading is telling you to go one way, take that as a sure sign you need to consider the oversold.”
Pre-open indications re-cap: 1 hit and 2 miss
Research note: Asterias Biotherapeutics (NYSEMKT: AST +$0.40) - BUY
I answer one question, in which company should investors commit and keep their money.
What have you missed, Tuesday’s results have implications to Wednesday's sector activity.
A daily report may say little or a lot and its final judgement may be inconclusive; yet it serves as insurance that all indications are being examined and evaluated.
The advance/decline line scenario of 43 SCGT & RT covered companies:
· The open was positive with an A/DL of 17/16 and 10 flats ;
· The mid-day was positive with an A/DL of 26/14 and 3 flats;
· The close was positive with an A/DL of 25/13 and 5 flat;
Pre-open indications re-cap: 1 hit and 2 miss …
- Brainstorm Cell Therapeutics (BCLI) closed up +$0.15 – hit;
- Juno Therapeutics (JUNO) closed UP +$0.26 – miss;
- Kite Therapeutics (KITE) closed up +$3.10 – miss;
Henry’omics:
From the pre-open’s investor’s newsletter … “Zig when others zag - Thoughts on going against the grain … which way is the sector telling investors to go?”
- Reiterating, “Downside trading is telling you to go one way, take that as a sure sign you need to consider the oversold … Remember, Friday is an expiration day for options – are they in the money? After a withdrawal, there is always a need to consolidate and regain some territory.”
It’s important to note that the last two days have shown little to no real signs of strength as even today was weak as to a few equities … other than BLUE, ONCE, KITE, JUNO and the news from AST that helped its mothership - BTX.
Daily analytics:
U.S. equities closed DOWN on Tuesday … with the DOW closing UP +0.44% (+92.80) as the NASDAQ closed UP +0.73% (+44.90) …
… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded near 10.27 …
· Monday traded 11.48 – up +7.29% after Friday traded near 10.6, Thursday’s near 10.2 … 1.5% lower after Wednesday’s near 10.32 - -1.24% and last Tuesday’s 10.5 …
Welcome to another day of the sector’s roller coaster …
… The iShares Russell 2000 (IWM) indicated a positive +0.18% at the pre-open and closed
· Tuesday traded UP +0.51%,
· Monday -0.16%,
· Friday+0.52%
· Thursday +1.34%
· Wednesday +0.10%
· Last Tuesday -0.09%
… The iShares NASDAQ Biotechnology (IBB) indicated a positive +0.27% in the pre-open and closed
· Tuesday traded UP +0.41%
· Monday -0.30%,
· Friday -0.22%
· Thursday +0.63%
· Wednesday +0.06%
· Last Tuesday -0.46%
The count - decliners versus gainers:
……. look at the differences in the spreads ……….
· Tuesday’s decliners ranged from -0.61% <BLCM> to -9.82% <IMUC> in 13 equities;
· Monday’s decliners ranged from -0.31% <BTX> to -7.83% <ISCO> in 22 equities;
· Friday’s decliners ranged from -0.39% <QURE> to -8.68% <MESO> in 29 equities;
· Thursday’s decliners ranged from -0.30% <FATE> to -8.33% <ISCO> in 12 equities;
· Wednesday’s decliners ranged from -0.45% <BLFS> to -7.72% <NWBO> in 21 equities;
· Last Tuesday’s decliners ranged from -0.37% <ONCE> to -6.98% <NWBO> in 19 equities;
Versus
· Tuesday’s gainers ranged from +0.26% <CLLS> to +12.70% <AST> in 26 equities;
· Monday’s gainers ranged from +0.13% <ONCE> to +15.20% <FCSC> in 15 equities;
· Friday’s gainers ranged from +0.63% <BTX> to +5% <AGTC> in 13 equities;
· Thursday’s gainers ranged from +0.12% <CLLS> to +7.26% <MESO> in 30 equities;
· Wednesday’s gainers ranged from +0.27% <XON> to +11.15% <BLUE> in 16 equities;
· Last Tuesday’s gainers ranged from +0.12% <CLLS> to +7.56% <BLUE> in 18 equities;
Some of MY working trend lines or indications for tomorrow:
… The greatest volume to the downside: RENE.L, NWBO, XON, BLCM and ONVO
… Upside volume was weighted to: JUNO, KITE, BLUE, MDXG and BTX
… Biggest $ downside: RGNX, XON, MESO, IMUC and ADRO
… Largest $ upside: KITE, BLUE, ONCE, AST and JUNO
… Flats: BSTG, CLBS, ADVM, SGMO and BLFS
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
